Stay up to date with news and events
Wave Life Sciences Announces Positive Results from Phase 1B/2A SELECT-HD Trial
June 26, 2024
Great news on the positive results! Read all the details below. Community Letter Press Release
Highlights from the 2024 CHDI HD Therapeutics Conference
May 21, 2024
Highlights from the 2024 CHDI HD Therapeutics Conference || Palm Springs 26 – 29 February 2024 Including Clinical Trial updates from PTC Therapeutics, Wave Life…
uniQure gets the green light to resume testing HD gene therapy
November 5, 2022
In August 2022, uniQure announced a pause in new recruitment for their trial of AMT-130, an HD gene therapy delivered via brain surgery. The decision…
WAVE Announcement
October 1, 2021
Wave Life Sciences Announces Initiation of Dosing in Phase 1b_2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease